Double Marker FMF Certified
The double marker test evaluates the risk of chromosomal abnormalities in pregnancy. Using the AutoDELFIA method, it provides an accurate screening for conditions like Down syndrome.
Double Marker FMF Certified Test in Mangaluru Overview
About this test
Double Marker FMF approved is a prenatal screening test performed during the first trimester of pregnancy, typically between 9 to 13 weeks. The double marker FMF approved test measures two important biochemical markers in the mother’s blood free Beta hCG and PAPP-A (Pregnancy Associated Plasma Protein-A). These markers, when combined with ultrasound findings like NT scan, help assess the risk of chromosomal abnormalities such as Down syndrome (Trisomy 21), Trisomy 18, and Trisomy 13.
The double marker FMF approved is especially valuable because it is approved by the Fetal Medicine Foundation (FMF), ensuring standardized and reliable risk assessment. The double marker FMF approved test does not diagnose conditions but provides a probability score to guide further testing if needed. Doctors often recommend double marker FMF approved test as part of routine antenatal care.
Key points:
- First trimester prenatal screening test
- Measures free Beta hCG and PAPP-A
- Helps assess risk of chromosomal abnormalities
- Non-invasive blood test
- FMF-approved for accuracy and standardization
Why consider this test?
The double marker FMF approved is crucial for early detection of potential chromosomal abnormalities. Early screening through the double marker FMF approved allows expecting parents and doctors to make informed decisions regarding further diagnostic procedures such as NIPT or amniocentesis.
The double marker FMF approved is particularly important because it helps identify high-risk pregnancies early, enabling timely medical intervention and better pregnancy management. The double marker test is widely recommended as part of first trimester screening protocols globally.
Key reasons:
- Early risk assessment of genetic conditions
- Helps plan further diagnostic tests
- Improves pregnancy monitoring
- Provides reassurance in low-risk cases
- Supports informed decision-making
Who should get tested?
The double marker FMF approved is recommended for all pregnant women, especially during the first trimester. However, the importance of the double marker FMF approved increases in certain cases such as advanced maternal age (above 35 years), history of genetic disorders, or previous pregnancy complications.
Doctors strongly advise double marker FMF approved for women undergoing assisted reproductive techniques like IVF, as well as those with abnormal ultrasound findings. The double marker FMF approved helps categorize pregnancies into low or high risk.
Recommended for:
- All pregnant women (9–13 weeks)
- Women above 35 years
- IVF pregnancies
- Family history of genetic disorders
- Abnormal NT scan findings
More Information
The double marker FMF approved is a safe, non-invasive blood test with no risk to the mother or fetus. A low-risk result from the double marker FMF approved typically requires no further testing, while a high-risk result may lead to additional screening or diagnostic tests.
It is important to note that the double marker FMF approved is a screening test and not a confirmatory diagnostic tool. Proper interpretation of the double marker FMF approved results should always be done by a qualified healthcare professional in conjunction with clinical findings.
Additional details:
- No fasting required
- Simple blood sample
- Results combined with ultrasound
- Screening, not diagnostic
- Follow-up may be required in high-risk cases
No special preparations needed
- Free Beta Human Chorionic Gonadotropin (fbhcg)
- Pregnancy Associated Plasma Protein A (papp-a)
- Corrected Free Beta Hcg Mom
- Corrected Papp-a Mom
- Corrected Nt Mom
- Trisomy 21 Screening With Nt
- Trisomy 13 Screening With Nt
- Trisomy 18 Screening With Nt
Test code
1268D
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Serum | Yellow Vacutainer | .5 ML |
| Serum Primary | .5 ML |
Specimen stability information
Serum, Serum Primary
Collection instructions
Risk assessment is calculated between 9-13.6 weeks of Gestation. Referring physicians name, contact detail and duly filled Maternal consent form is mandatory (Maternal Date of Birth,Maternal Weight, Maternal Race,Maternal H/O Type I Diabetes Mellitus + Obstetric USG Report between 10 to 13 weeks of gestation+Date of collection).
Specimen rejection criteria
Test run frequency
Every Day TIME - 09:00
Turn around time
Next Day
Performing locations
Department
- Maternal Marker
CPT and Loinc codes
Package price
₹2750
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book TestDouble Marker FMF Certified
₹2750